Cancer after Kidney Transplantation in the United States

By B. Kasiske, J. Snyder, D. Gilbertson, Changchun Wang. American Journal of Transplantation, 2004

1,063 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology

View Paper: https://www.semanticscholar.org/paper/62f09c77e8d004cf1bd1f56bcc295c283b726dea

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. humAn cArcinogens
2. peRsonAl hAbIts
3. Iarc Monographs
4. E. Woodle
5. H. Kauffman
6. W. Cherikh
7. J. Buell
8. T. Gross

Citations in the corpus

• iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns (2012, background): “A recent study of renal transplant recipients reported a more than 20-fold increased incidence of Kaposi sarcoma compared with the general population (Kasiske et al., 2004).”
• Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo Malignancies (2005, background): “Because older age, male gender, white race, previous history of malignancy, certain primary renal disease diagnoses (Table 5) and duration of immunosuppression (2) are significant risk factors for the development of posttransplantation de novo malignancy, adding a TOR inhibitor to the maintenance dr”
• Malignancy after Transplantation (2005, background): “Two studies confirm a significant increase in the incidence of SCC in patients receiving CsA, AZA, and prednisolone compared to those maintained on AZA and prednisolone (14).”